ArticleCancer chemotherapy and pharmacology2025

WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells.

João Marcos Oliveira-Silva et al.PubMed ↗Publisher ↗

No numbers read from the abstract.